Skip to main content
OpenTrials
Completed

NCT Number: NCT05914298

Height, Ulnar Length and Forearm Function in Multiple Hereditary Exostoses

the purpose of the present registry is to describe the epidemiology of forearm deformities in patients with Hereditary Multiple Exostoses and to identify, independent predictors of severity of the disease and potential association with genotypic patterns

Completed

Looking for future studies?

Notify Me

Key information

About this study

Hereditary Multiple Exostoses (HME) is a rare pediatric autosomal dominant disorder caused by loss-of-function mutations in the genes encoding the heparan sulfate (HS)-synthesizing enzymes EXT1 or EXT2. HME affects 1 in 50,000 people and has 100% penetrance but great variability in phenotypic expression. HME is characterized by formation of cartilaginous outgrowths, called osteochondromas or exostoses, next to the growth plates of many axial and appendicular skeletal elements, causing multiple, painful disfiguring and disabling skeletal deformities, and potential malignant transformation into peripherral chondrosarcoma.

The involvement of upper-limb bones by HME is associated with greater loss of function than elsewhere in the body, but even here the loss of function may be limited. Moreover, the constant relationship between height and ulnar length has long been recognized in forensic medicine and has been recently analyzed also in HME, in order to predict the clinical and functional outcomes of the upper limb.

the present registry aims to collect demographic, clinical, functional and radiographic information from patients with HME in order to establish phenotypic predictors of severity of the disease and potential association with genotypic patterns

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with HME (> 2 exostoses)

Exclusion criteria

  • Patients with solitary exostoses
  • Patients, adults or minors, who are unable to give their timely informed consent.

Treatment and study plan

blood and buccal swab genetic test

Diagnostic Test

blood samples and buccal swabs will be obtained from patients with HME in order to analyze the genotype (EXT1 or EXT2 mutations) and correlate the genotypic pattern with the phenotypic presentation

PUL

Diagnostic Test

measurement of ulnar length with anthropometer and patient's height

Range of Motion

Diagnostic Test

measurement of range of motion of elbow, forearm and wrist

Primary outcomes

  1. proportional ulnar length (PUL)

    Time frame: 1 year

    proportional ulnar length (PUL) is the ratio between ulnar lenght and the height of the patient

Secondary outcomes

  1. genotype

    Time frame: 1 year

    identify potential association among the genotypic pattern (EXT1 or EXT2) and phenotypic presentation

  2. forearm function

    Time frame: 1 year

    elbow, forearm and wrist range of motion (ROM) measured by a goneometer

  3. EuroQol 5D

    Time frame: 1 year

    EQ-5D is a standardised measure of health-related quality of life developed by the EuroQol Group

Sponsors and collaborators

Lead sponsor

Istituto Ortopedico Rizzoli

Other

Registry information

Official study title

Analysis of the Relationship Among Height, Ulnar Length and Forearm Function in Patients With Multiple Hereditary Exostoses and Association With the Genotypic Pattern

Important dates

Study start
2018
Primary completion
2021
Study completion
2022
First posted
Jun 22, 2023
Registry last updated
Jun 22, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.